DOXORUBICIN HYDROCHLORIDE
NDC 49315-008, doxorubicin hydrochloride, injectable, liposomal, from Zydus Lifesciences Limited.
- Product NDC
- 49315-008
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212299
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49315-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXORUBICIN HYDROCHLORIDE2 mg/mL
Pharmacologic classes
Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49315-008-03 | 49315000803 | 1 VIAL, SINGLE-DOSE in 1 CARTON (49315-008-03) / 10 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/bad467d4-7e27-4eda-b4d3-854460f0adab
Use it
Look up 49315-008 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49315-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49315-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.